Skip to content

Probiotic Beer to Enhance Gut Health and Immune System Function

Probiotic Beer to Enhance Gut Health and Immune System Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05401604
Acronym
PBEER
Enrollment
30
Registered
2022-06-02
Start date
2021-08-27
Completion date
2022-02-18
Last updated
2022-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Nutrition, Healthy

Brief summary

This study investigates the immunological and gut microbiome effects of moderate probiotic beer consumption.

Detailed description

Studies have shown that moderate alcohol consumption and probiotics have each shown immunomodulatory anti-inflammatory effects. However, to our knowledge, the effect of adding a probiotic strain to a beer drink, together with moderate alcohol consumption, on immunity and gut microbiome has yet to be studied. The probiotic beer used in this study taps on this unexplored research area and may potentially serve as a more healthful option to consumers than normal beer in the future, given the vast popularity of this beverage and probiotics.

Interventions

DIETARY_SUPPLEMENTModerate probiotic beer consumption

Consumption of one can of probiotic beer per day for 14 days. Blood and fecal samples will be collected at the start and end of the intervention to analyse for immunological biomarkers and gut microbiome.

DIETARY_SUPPLEMENTModerate normal beer consumption

Consumption of one can of normal beer per day for 14 days. Blood and fecal samples will be collected at the start and end of the intervention to analyse for immunological biomarkers and gut microbiome.

Sponsors

National University of Singapore
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Participants are blinded as to which beer (i.e. normal or probiotic) they are receiving for each intervention arm.

Intervention model description

The experimental design used in this study is a randomised, controlled, within-subject cross-over design. Each individual will undergo a 2-week intervention each of moderate beer consumption and moderate probiotic beer consumption, with a 1-week period of washout in between. The total study duration will be 5 weeks.

Eligibility

Sex/Gender
MALE
Age
21 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Ability to give informed consent. * 21 - 60 years of age (inclusive) at screening. * Healthy male, as determined by medical history, physical examination and laboratory results within normal reference range for the population or investigator site, or results with acceptable deviations that are judged to be not clinically significant by the investigator. * Race must be Chinese. * Willing to consume 1 beer can per day for 14 days. * Not on any regular medications (western/ traditional). * No family history of alcoholism.

Exclusion criteria

* Female. * A current smoker, have smoked, or is a user of tobacco products for the past 2 years. * History or presence of current lipid and cardiovascular disorders, respiratory, hepatic, renal, gastrointestinal, endocrine, lipid disorder, haematological, malignancy or neurological disorders capable of significantly altering the performance of the biomarker panel; or of interfering with the interpretation of data. * History of alcoholism, alcohol dependence, alcohol abuse, alcohol allergy and/or any other alcohol use disorders. * History of Type 1/ Type 2 diabetes and use of anti-diabetic medications in the past. * Regular use of medication that are known to have an effect on immune function. * Regular use of aspirin. * A naïve alcohol drinker. * Persons with known or ongoing psychiatric disorders or drug abuse within 3 years. * Active infection requiring systemic antiviral or antimicrobial therapy that will not be completed prior to first visit of the study. * Treatment with any investigational drug, or biological agent within one (1) month of screening or plans to enter into an investigational drug/ biological agent study during the duration of this study. * Significant change in weight (+/- 5%) during the past month. * Antibiotic use in the past 2 months.

Design outcomes

Primary

MeasureTime frameDescription
Changes in inflammatory cytokine profile after moderate probiotic beer consumption.5 weeksChanges in inflammatory cytokine profile (IFNg, TNFa, IL-1b, IL-2, IL-4, IL-6, IL-10, IL-12) in blood samples of individuals after moderate probiotic beer consumption, in comparison to moderate normal beer consumption.
Changes in gut microbiome profile after moderate probiotic beer consumption.5 weeksChanges in gut microbiome profile from DNA sequencing in stool samples after moderate probiotic beer consumption, in comparison to moderate normal beer consumption.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026